Novavax
MD · 16 filings, 2025
Lobbying spend · 2025
$700K
to shape legislation
About the organization
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medical/Disease Research/Clinical Labs · Budget/Appropriations · Trade (domestic/foreign)
2Through these firms · 5
BALLARD PARTNERSCROWELL & MORING LLPNOVAVAX, INCBROWNSTEIN HYATT FARBER SCHRECK, LLPCROSSROADS STRATEGIES, LLC
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews